LMR Partners’s Outset Medical OM Stock Holding History

LMR Partners’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,333	Closed	-$2.47M	–	1240
2021 Q3	$2.47M	Buy	+3,333	New	+$2.27M	0.03%	403

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LMR Partners's OM Position: Q4 2021 in Review

LMR Partners sold out of Outset Medical (OM) in Q4 2021, closing a stake of 3,333 shares — an estimated $2.47M sold.

LMR Partners first reported a position in OM in Q3 2021 and held it in 1 quarter. The position peaked at $2.47M in Q3 2021. 156 funds tracked by Wall St. Rank hold OM as of Q4 2021.

LMR Partners reported no remaining Outset Medical position as of Q4 2021 after selling out during the quarter.
LMR Partners sold 3,333 Outset Medical shares in Q4 2021, an estimated $2.47M.
LMR Partners first reported a position in Outset Medical in Q3 2021 and held it in 1 quarter.
LMR Partners's Outset Medical position peaked at $2.47M in Q3 2021.
156 funds tracked by Wall St. Rank held Outset Medical as of Q4 2021.

Based on LMR Partners's 13F filing for Q4 2021, filed 14 Feb 2022.